Product

Dexamethasone Intravitreal Implant

1 clinical trial

1 indication

Indication

Diabetic Macular Edema

Clinical trial

A 12-month, Prospective, Open-label, Phase 4 Study to Evaluate the Efficacy and Safety of OZURDEX® (Dexamethasone Intravitreal Implant) in Treatment Naïve Patients (According to Standard Clinical Practice) With Diabetic Macular Edema

Status: Completed, Estimated PCD: 2022-07-04